Tetra Bio-Pharma to File PPP001 With the European Medicines Agency
Tetra Bio-Pharma Inc. today announced it is ready to submit its PPP001 cannabinoid-derived drug as a herbal medicinal product to the European Medicines Agency.
Tetra Bio-Pharma Inc. today announced it is ready to submit its PPP001 cannabinoid-derived drug as a herbal medicinal product to the European Medicines Agency.